School of Medicine

In a small study, researchers at Washington University School of Medicine found that only women whose tumors responded to estrogen challenge benefited from hormone therapy. The findings could help doctors choose the treatments most likely to help their patients.

James M. DuBois, the Steven J. Bander Professor of Medical Ethics and Professionalism, and Kenneth M. Ludmerer, MD, the Mabel Dorn Reeder Distinguished Professor of the History of Medicine at Washington University School of Medicine in St. Louis, have been named Hastings Center Fellows. The Hastings Center addresses social and ethical issues in health care, science and technology.

Researchers at Washington University School of Medicine have used light to decode brain signals and identify what image a person sees. It could be a step toward helping people who are unable to express themselves because of brain injury or disease communicate.

Researchers at Washington University School of Medicine have engineered cartilage cells to release an anti-inflammatory drug in response to stresses such cells undergo when they are compressed during weight bearing and movement.

Researchers at Washington University School of Medicine have found that immune cells stationed in such sinuses monitor the brain and initiate an immune response if they detect a problem.

A new study from Washington University School of Medicine suggests that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer.

Michael S. Kinch, associate vice chancellor and director of the Centers for Research Innovation in Biotechnology and Drug Discovery, and professor of biochemistry and molecular biophysics at the School of Medicine,, received a one-year $280,385 grant from Arnold Ventures for his research titled “CDEK: Clinical Data Experience Knowledge-base.”

Alex Holehouse, assistant professor of biochemistry and molecular biophysics at the School of Medicine, received a one-year $91,539 grant from Dewpoint Therapeutics for his research titled “Bioinformatic tools for the analysis of phase separating proteins.”

Researchers at Washington University School of Medicine have developed an imaging agent that could help refine assessments of kidney health, potentially salvaging some otherwise discarded donor kidneys.

Ebony Boyce Carter, MD, a physician-scientist known for her research involving community-based interventions to promote health equity for pregnant women and their babies, has been named director of the Division of Clinical Research in the Department of Obstetrics & Gynecology at the School of Medicine.